ML Capital Group, Inc. (OTCQB: MLCG) (OTCBB: MLCG) is pleased to commend the medical industry for showing its support in the use of medical marijuana and WebMD/Medscape for publishing its medical marijuana industry survey.
The medical marijuana industry has been at the brunt of controversy and late night talk show jokes for quite some time, however, it is also now considered to be one of the hottest industries to be in due to the increased legalization and medical allowance mandates that have been established in over 20 states, with 10 additional states in pending legislation. In a recent survey taken by WebMD, published just yesterday, the overwhelming results show that a majority of the doctors say that medical marijuana should be legalized on a national basis and that it can deliver real benefits to patients.
WebMD's website for health professionals conducted the survey which included 1,544 doctors, coming from more than 12 specialties and 48 states, provided conclusive evidence of the medical community's support of medical marijuana. Some of the numbers that came from the survey include:
- 69% said it can help with certain treatments and conditions
- 67% said it should be a medical option for patients
- 56% support making it legal nationwide
- 50% of doctors in states where it is not legal said it should be legal in their state
- 52% of doctors in states considering new laws said it should be legal in their state
Support for medical marijuana also varied by the doctor's specialty. For instance, oncologists and hematologists showed the highest level, with 82% saying marijuana delivers real benefits to patients. These specialties are also the most likely to say that marijuana should be a medical option for patients as it is prescribed and used to treat cancer pain, nausea related to chemotherapy, and to stimulate appetite.
"The medical community is clearly saying they support using marijuana as a potential treatment option for any number of medical problems. In fact, many doctors already prescribe it," stated WebMD Chief Medical Editor Michael W. Smith, MD.
Medical marijuana is commonly found as a treatment for seizure disorders and sleeping disorders, as well as to treat chronic pain from injuries or medical conditions such as cancer, nausea from medication, and multiple sclerosis.
Mrs. Lisa Nelson, the Company's President and CEO, stated "the results of this survey and the endorsement by the medical community is incredible news for the medical marijuana industry as it is finally recognized on a larger national scale that is provides true benefits to its patients. It's very commendable of WebMD to put this survey together and publish it. In addition, this news also helps to validate the potential of ML Capital's business model by the broad acceptance of medical marijuana and its wide ranging applications by the medical community."
As recently announced, the Company is currently working on several different business initiatives in the medical marijuana industry that are expected to be commercialized in the very near future. These initiateives include the launch of the SuperStar Vapor Pen, the publishing and upcoming release of the SuperStar MMJ Recipes book, as well as its new smartphone application, SuperStar MMJ Dispensaries.
About ML Capital Group, Inc.:
ML Capital Group, Inc.'s primary business consists of providing management, financial and strategic consulting services designed to advance and improve an organization's ability to conduct its business more effectively and to foster sales growth, with a principal focus on assisting companies in the green technology industry as well as produces, markets and sells its own branded products that are specifically focused on the medical marijuana, or "green medicine", industry.
ML Capital Group's stock is traded on the OTC Bulletin Board and OTC Markets where it is qualified to be listed in the QB marketplace as a current reporting company. You can access the Company's stock quote directly from OTC Markets atwww.otcmarkets.com/stock/MLCG/quote. To find out more information on the Company, visit its website at www.mlcapitalgroupinc.com.
Safe Harbor Statement:
This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Contact:
Investor Relations
Stuart T. Smith
512-267-2430
info@smallcapvoice.com
Associated Documentation:
Link to submission on http://www.eteligis.com
MLCG_04-03-14_MAQ_ETL.docx
To unsubscribe from any future mailings, please visit: http://www.eteligis.com/MassMailUnsubscribe.aspx
Copyright eTeligis Inc. 2014. All rights reserved.
0 comments:
Post a Comment